Nebulized levofloxacin for chronic Burkholderia cenocepacia pulmonary infection in cystic fibrosis: A case report
We present a patient with cystic fibrosis who used nebulized levofloxacin off-label to suppress chronic Burkholderia cenocepacia pulmonary infection. The patient was initially using tobramycin inhalation powder (TIP) off-label continuously for suppression of chronic B. cenocepacia; this was changed...
Main Authors: | Renée VE. Dagenais, Bradley S. Quon, Alessandro N. Franciosi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Respiratory Medicine Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007122001940 |
Similar Items
-
Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients
by: Bryan A. Garcia, et al.
Published: (2018-02-01) -
Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy?
by: Alex eHorsley, et al.
Published: (2011-12-01) -
Nebulizer Care and Inhalation Technique in Children with Cystic Fibrosis
by: Argyri Petrocheilou, et al.
Published: (2020-09-01) -
Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada
by: David P. Speert, et al.
Published: (2002-02-01) -
Comparason of extraction methods for PCR detection of Burkholderia cepacia complex (BCC) from cystic fibrosis patients
by: Ergunay Koray, et al.
Published: (2008-06-01)